Drugs by condition
Drugs approved for narcolepsy
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
10
Still marketed, NDA or BLA
Drug classes
3
Novel drugs
3
New molecular entities and new biologics
In development
4
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for narcolepsy.
- Lumryz (Sodium Oxybate) · Alkermes INC OrphanMay 1, 2023
- Wakix (Pitolisant Hydrochloride) · Harmony Breakthrough therapyPriority reviewOrphanOct 13, 2020
- Xywav (Calcium Oxybate, Magnesium Oxybate, Potassium Oxybate, Sodium Oxybate) · Jazz Priority reviewOrphanJul 21, 2020
- Sunosi (Solriamfetol Hydrochloride) · Axsome Malta NovelOrphanMar 20, 2019
- Nuvigil (Armodafinil) · Nuvo Pharms Jun 15, 2007
All approved drugs for narcolepsy, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 74 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Dopamine and Norepinephrine Reuptake Inhibitor (1)
- Sunosi Solriamfetol Hydrochloride · Axsome Malta · 2019
Sympathomimetic-like Agent (1)
- Provigil Modafinil · Nuvo Pharms · 1998
Class not listed in FDA's data (8)
- Xyrem Sodium Oxybate · Jazz Pharms · 2002
- Lumryz Sodium Oxybate · Alkermes INC · 2023
- Wakix Pitolisant Hydrochloride · Harmony · 2020
- Xywav Calcium Oxybate, Magnesium Oxybate, Potassium Oxybate, Sodium Oxybate · Jazz · 2020
- Nuvigil Armodafinil · Nuvo Pharms · 2007
- Methylin Methylphenidate Hydrochloride · Specgx LLC · 2002
- Dexedrine Spansule Dextroamphetamine Sulfate · Impax Labs INC · 1976
- Ritalin Methylphenidate Hydrochloride · Sandoz · 1955
Drugs in development for narcolepsy
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- ALKS 2680AlixorextonPhase 37 trials
Alkermes, Inc. · Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
- TAK-360Phase 34 trials
Takeda · Narcolepsy Type 1, Idiopathic Hypersomnia, Narcolepsy Type 2
- ORX750Phase 22 trials
Centessa Pharmaceuticals (UK) Limited · Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
- E2086Phase 21 trial
Eisai · Narcolepsy
More on narcolepsy: recruiting trials · published research
Related in neurology: Alzheimer's disease · Parkinson's disease · Multiple sclerosis · Epilepsy and seizures · Migraine · ALS (amyotrophic lateral sclerosis) · Myasthenia gravis · Spinal muscular atrophy · Duchenne muscular dystrophy · Huntington's disease chorea
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.